Oncolys BioPharma: Announcements of the issuance of the 20th subscription rights (with exercise price adjustment clause and exercise suspension clause) through third-party allocation have been completed for payment.

JPX · Jul 1 14:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

オンコリスバイオファーマ：第三者割当による第20回新株予約権（行使価額修正条項付及び行使停止条項付）の発行に係る払込完了に関するお知らせ

Oncolys BioPharma: Announcements of the issuance of the 20th subscription rights (with exercise price adjustment clause and exercise suspension clause) through third-party allocation have been completed for payment.

Risk Disclaimer

Statement